Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease

Neuroscience Letters

Volumn 366, Issue 3, 2004, Pages 326-331

  Deng, Yifu ^a   Newman, Beth ^a   Dunne, Michael P ^a   Silburn, Peter A ^b   Mellick, George D ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Case only study; Genetic polymorphism; Glutathione S transferase; Interaction; Parkinson's disease

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ACYLTRANSFERASES; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RISK; SMOKING;

EID: 3543085181     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.05.061     Document Type: Article

References (20)

1. Abdel-Rahman S.Z., el-Zein R.A., Anwar W.A., Au W.W. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 107:1996;229-233
2. Albert P.S., Ratnasinghe D., Tangrea J., Wacholder S. Limitations of the case-only design for identifying gene-environment interactions. Am. J. Epidemiol. 154:2001;687-693
3. Buchanan D.D., Silburn P.A., Chalk J.B., Le Couteur D.G., Mellick G.D. The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients. Neurosci. Lett. 327:2002;91-94
4. Checkoway H., Franklin G.M., Costa-Mallen P., Smith-Weller T., Dilley J., Swanson P.D., Costa L.G. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology. 50:1998;1458-1461
5. De Palma G., Mozzoni P., Mutti A., Calzetti S., Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet. 352:1998;1986-1987
6. Fratiglioni L., Wang H.X. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav. Brain Res. 113:2000;117-120
7. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment? Cancer Epidemiol. Biomarkers Prev. 10:2001;1233-1237
8. Kelada S.N., Stapleton P.L., Farin F.M., Bammler T.K., Eaton D.L., Smith-Weller T., Franklin G.M., Swanson P.D., Longstreth W.T. Jr., Checkoway H. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci. Lett. 337:2003;5-8
9. Khoury M.J., Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol. 144:1996;207-213
10. Kwok J.B., Teber E., Loy C., Hallupp M., Nicholson G., Mellick G.D., Buchanan D.D., Silburn P.A., Schofield P.R. Tau promoter haplotypes regulate transcription and are associated with Parkinson's disease. Ann. Neurol. 55:2004;329-334
11. Le Couteur D.G., Muller M., Yang M.C., Mellick G.D., McLean A.J. Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease. Rev. Environ. Health. 17:2002;51-64
12. Levecque C., Elbaz A., Clavel J., Richard F., Vidal J.S., Amouyel P., Tzourio C., Alperovitch A., Chartier-Harlin M.C. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum. Mol. Genet. 12:2003;79-86
13. Mellick G.D., Buchanan D.D., Hattori N., Brookes A.J., Mizuno Y., Le Couteur D.G., Silburn P. The Parkin gene S/N167 polymorphism in Australian Parkinson's disease patients and controls. Parkinsonism Relat. Disord. 7:2001;89-91
14. Mellick G.D., McCann S.J., Le Couter D.G. Parkinson's disease, MAOB, and smoking. Neurology. 53:1999;658
15. Mellick G.D., Silburn P.A. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease. Neurosci. Lett. 293:2000;127-130
16. Mellick G.D., Silburn P.A., Prince J.A., Brookes A.J. A novel screen for nuclear mitochondrial gene associations with Parkinson's disease. J. Neural Transm. 112:2004;191-199
17. Menegon A., Board P.G., Blackburn A.C., Mellick G.D., Le Couteur D.G. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet. 352:1998;1344-1346
18. Piegorsch W.W., Weinberg C.R., Taylor J.A. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat. Med. 13:1994;153-162
19. Tan E.K., Chai A., Lum S.Y., Shen H., Tan C., Teoh M.L., Yih Y., Wong M.C., Zhao Y. Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: a study in an Asian population. Am. J. Med. Genet. 120B:2003;58-62
20. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins: an etiologic study. J. Am. Med. Assoc. 281:1999;341-346